![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 42, 39145-39149, October 19, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of The function of the cellular prion protein (PrP)
is still poorly understood. We present here an unprecedented role for
PrP against Bax-mediated neuronal apoptosis and show that PrP
potently inhibits Bax-induced cell death in human primary
neurons. Deletion of four octapeptide repeats of PrP (PrP
Prion Protein Protects Human Neurons against
Bax-mediated Apoptosis*
§,
§,
**
Neurology and Neurosurgery,
and ¶ Pediatrics, McGill University, Montréal, PQ,
H3A 2T5 Canada and the
Bloomfield Center for Research in
Aging, The Lady Davis Institute for Medical Research, Sir Mortimer B. Davis, Jewish General Hospital, Montreal, Quebec, H3T 1E2 Canada
OR)
and familial D178N and T183A PrP mutations completely or partially
eliminate the neuroprotective effect of PrP. PrP remains
anti-apoptotic despite truncation of the
glycosylphosphatidylinositol (GPI) anchor signal peptide,
indicating that the neuroprotective form of PrP does not require the
abundant cell surface GPI-anchored PrP. Our results implicate PrP as a
potent and novel anti-apoptotic protein against Bax-mediated cell death.
*
This work was supported by Grant MT-13464 from the Medical
Research Council of Canada and Fonds de Recherche en Santé du Québec (to A. L. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
D. Yoshikawa, N. Yamaguchi, D. Ishibashi, H. Yamanaka, N. Okimura, Y. Yamaguchi, T. Mori, H. Miyata, K. Shigematsu, S. Katamine, et al. Dominant-negative Effects of the N-terminal Half of Prion Protein on Neurotoxicity of Prion Protein-like Protein/Doppel in Mice J. Biol. Chem., August 29, 2008; 283(35): 24202 - 24211. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani Physiology of the Prion Protein Physiol Rev, April 1, 2008; 88(2): 673 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Kovacs and H. Budka Prion Diseases: From Protein to Cell Pathology Am. J. Pathol., March 1, 2008; 172(3): 555 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meslin, A. Hamai, P. Gao, A. Jalil, N. Cahuzac, S. Chouaib, and M. Mehrpour Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell Death Cancer Res., November 15, 2007; 67(22): 10910 - 10919. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meslin, R. Conforti, C. Mazouni, N. Morel, G. Tomasic, F. Drusch, M. Yacoub, J. C. Sabourin, J. Grassi, S. Delaloge, et al. Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer Ann. Onc., November 1, 2007; 18(11): 1793 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Nicolas, R. Gavin, N. Braun, J. M. Urena, X. Fontana, E. Soriano, A. Aguzzi, and J. Antonio del Rio Bcl-2 overexpression delays caspase-3 activation and rescues cerebellar degeneration in prion-deficient mice that overexpress amino-terminally truncated prion FASEB J, October 1, 2007; 21(12): 3107 - 3117. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jodoin, S. Laroche-Pierre, C. G. Goodyer, and A. C. LeBlanc Defective Retrotranslocation Causes Loss of Anti-Bax Function in Human Familial Prion Protein Mutants J. Neurosci., May 9, 2007; 27(19): 5081 - 5091. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li, S. J. Barmada, K. A. Roth, and D. A. Harris N-Terminally Deleted Forms of the Prion Protein Activate Both Bax-Dependent and Bax-Independent Neurotoxic Pathways J. Neurosci., January 24, 2007; 27(4): 852 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pan, L. Zhao, J. Liang, J. Liu, Y. Shi, N. Liu, G. Zhang, H. Jin, J. Gao, H. Xie, et al. Cellular prion protein promotes invasion and metastasis of gastric cancer FASEB J, September 1, 2006; 20(11): 1886 - 1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ballerini, P. Gourdain, V. Bachy, N. Blanchard, E. Levavasseur, S. Gregoire, P. Fontes, P. Aucouturier, C. Hivroz, and C. Carnaud Functional Implication of Cellular Prion Protein in Antigen-Driven Interactions between T Cells and Dendritic Cells. J. Immunol., June 15, 2006; 176(12): 7254 - 7262. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Novitskaya, O. V. Bocharova, I. Bronstein, and I. V. Baskakov Amyloid Fibrils of Mammalian Prion Protein Are Highly Toxic to Cultured Cells and Primary Neurons J. Biol. Chem., May 12, 2006; 281(19): 13828 - 13836. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Weise, R. Sandau, S. Schwarting, O. Crome, A. Wrede, W. Schulz-Schaeffer, I. Zerr, and M. Bahr Deletion of Cellular Prion Protein Results in Reduced Akt Activation, Enhanced Postischemic Caspase-3 Activation, and Exacerbation of Ischemic Brain Injury Stroke, May 1, 2006; 37(5): 1296 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Lopes, G. N. M. Hajj, A. G. Muras, G. L. Mancini, R. M. P. S. Castro, K. C. B. Ribeiro, R. R. Brentani, R. Linden, and V. R. Martins Interaction of Cellular Prion and Stress-Inducible Protein 1 Promotes Neuritogenesis and Neuroprotection by Distinct Signaling Pathways J. Neurosci., December 7, 2005; 25(49): 11330 - 11339. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-C. Shyu, S.-Z. Lin, M.-F. Chiang, D.-C. Ding, K.-W. Li, S.-F. Chen, H.-I Yang, and H. Li Overexpression of PrPC by Adenovirus-Mediated Gene Targeting Reduces Ischemic Injury in a Stroke Rat Model J. Neurosci., September 28, 2005; 25(39): 8967 - 8977. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brini, M. Miuzzo, N. Pierobon, A. Negro, and M. C. Sorgato The Prion Protein and Its Paralogue Doppel Affect Calcium Signaling in Chinese Hamster Ovary Cells Mol. Biol. Cell, June 1, 2005; 16(6): 2799 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Radovanovic, N. Braun, O. T. Giger, K. Mertz, G. Miele, M. Prinz, B. Navarro, and A. Aguzzi Truncated Prion Protein and Doppel Are Myelinotoxic in the Absence of Oligodendrocytic PrPC J. Neurosci., May 11, 2005; 25(19): 4879 - 4888. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li and D. A. Harris Mammalian Prion Protein Suppresses Bax-induced Cell Death in Yeast J. Biol. Chem., April 29, 2005; 280(17): 17430 - 17434. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fioriti, S. Dossena, L. R. Stewart, R. S. Stewart, D. A. Harris, G. Forloni, and R. Chiesa Cytosolic Prion Protein (PrP) Is Not Toxic in N2a Cells and Primary Neurons Expressing Pathogenic PrP Mutations J. Biol. Chem., March 25, 2005; 280(12): 11320 - 11328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Levine, D. Mitra, A. Sharma, C. L. Smith, and R. S. Hegde The Efficiency of Protein Compartmentalization into the Secretory Pathway Mol. Biol. Cell, January 1, 2005; 16(1): 279 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Drisaldi, J. Coomaraswamy, P. Mastrangelo, B. Strome, J. Yang, J. C. Watts, M. A. Chishti, M. Marvi, O. Windl, R. Ahrens, et al. Genetic Mapping of Activity Determinants within Cellular Prion Proteins: N-TERMINAL MODULES IN PrPC OFFSET PRO-APOPTOTIC ACTIVITY OF THE DOPPEL HELIX B/B' REGION J. Biol. Chem., December 31, 2004; 279(53): 55443 - 55454. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li, J. Dong, and D. A. Harris Cell Surface Expression of the Prion Protein in Yeast Does Not Alter Copper Utilization Phenotypes J. Biol. Chem., July 9, 2004; 279(28): 29469 - 29477. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Duxbury, H. Ito, E. Benoit, T. Waseem, S. W. Ashley, and E. E. Whang A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabine Chemoresistance in Pancreatic Adenocarcinoma Cells Cancer Res., June 1, 2004; 64(11): 3987 - 3993. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Anderson, D. Rossi, J. Linehan, S. Brandner, and C. Weissmann Transgene-driven expression of the Doppel protein in Purkinje cells causes Purkinje cell degeneration and motor impairment PNAS, March 9, 2004; 101(10): 3644 - 3649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diarra-Mehrpour, S. Arrabal, A. Jalil, X. Pinson, C. Gaudin, G. Pietu, A. Pitaval, H. Ripoche, M. Eloit, D. Dormont, et al. Prion Protein Prevents Human Breast Carcinoma Cell Line from Tumor Necrosis Factor {alpha}-Induced Cell Death Cancer Res., January 15, 2004; 64(2): 719 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Paitel, C. Sunyach, C. Alves da Costa, J.-C. Bourdon, B. Vincent, and F. Checler Primary Cultured Neurons Devoid of Cellular Prion Display Lower Responsiveness to Staurosporine through the Control of p53 at Both Transcriptional and Post-transcriptional Levels J. Biol. Chem., January 2, 2004; 279(1): 612 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Mastrianni and R. P. Roos Wrinkles and folds of the prion protein Neurology, November 11, 2003; 61(9): 1168 - 1169. [Full Text] [PDF] |
||||
![]() |
X. Roucou, Q. Guo, Y. Zhang, C. G. Goodyer, and A. C. LeBlanc Cytosolic Prion Protein Is Not Toxic and Protects against Bax-mediated Cell Death in Human Primary Neurons J. Biol. Chem., October 17, 2003; 278(42): 40877 - 40881. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, Y. Hong, Y. Bounhar, M. Blacker, X. Roucou, O. Tounekti, E. Vereker, W. J. Bowers, H. J. Federoff, C. G. Goodyer, et al. p75 Neurotrophin Receptor Protects Primary Cultures of Human Neurons against Extracellular Amyloid {beta} Peptide Cytotoxicity J. Neurosci., August 13, 2003; 23(19): 7385 - 7394. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Atarashi, N. Nishida, K. Shigematsu, S. Goto, T. Kondo, S. Sakaguchi, and S. Katamine Deletion of N-terminal Residues 23-88 from Prion Protein (PrP) Abrogates the Potential to Rescue PrP-deficient Mice from PrP-like Protein/Doppel-induced Neurodegeneration J. Biol. Chem., August 1, 2003; 278(31): 28944 - 28949. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aguzzi and W.-D. Hardt Dangerous Liaisons between a Microbe and the Prion Protein J. Exp. Med., July 7, 2003; 198(1): 1 - 4. [Full Text] [PDF] |
||||
![]() |
C. I. Lasmezas Putative functions of PrPC Br. Med. Bull., June 1, 2003; 66(1): 61 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Paitel, R. Fahraeus, and F. Checler Cellular Prion Protein Sensitizes Neurons to Apoptotic Stimuli through Mdm2-regulated and p53-dependent Caspase 3-like Activation J. Biol. Chem., March 14, 2003; 278(12): 10061 - 10066. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Qin, J. Coomaraswamy, P. Mastrangelo, Y. Yang, S. Lugowski, C. Petromilli, S. B. Prusiner, P. E. Fraser, J. M. Goldberg, A. Chakrabartty, et al. The PrP-like Protein Doppel Binds Copper J. Biol. Chem., March 7, 2003; 278(11): 8888 - 8896. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. van Rheede, M. M. W. Smolenaars, O. Madsen, and W. W. de Jong Molecular Evolution of the Mammalian Prion Protein Mol. Biol. Evol., January 1, 2003; 20(1): 111 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, R. McLaughlin, C. Goodyer, and A. LeBlanc Selective cytotoxicity of intracellular amyloid {beta} peptide1-42 through p53 and Bax in cultured primary human neurons J. Cell Biol., February 4, 2002; 156(3): 519 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, R. McLaughlin, C. Goodyer, and A. LeBlanc Selective cytotoxicity of intracellular amyloid {beta} peptide1-42 through p53 and Bax in cultured primary human neurons J. Cell Biol., February 4, 2002; 156(3): 519 - 529. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |